0
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- B of A Securities analyst Geoff Meacham upgraded the rating for Tyra Biosciences, Inc. (NASDAQ:TYRA) from Neutral to Buy and raised the price target from $22 to $31. Tyra Biosciences shares closed at $25.98 on Thursday. See how other analysts view this stock.
- Morgan Stanley analyst Michael Cyprys upgraded Victory Capital Holdings, Inc. (NASDAQ:VCTR) from Underweight to Equal-Weight and increased the price target from $40 to $60. Victory Capital shares closed …
Full story available on Benzinga.com
Visited 1 times, 1 visit(s) today
